Various neuroinflammation markers, including NFκB, IL1‐β, IFN‐γ, TNF‐α, and p‐MAPK, are misregulated in the brains of patients with AD (see Figure 3a) (Fan et al., 2020; Saito & Saido, 2018; Skaper, Facci, Zusso, & Giusti, 2018). This evidence concerns the gene IFNG and Alzheimer disease.